Research and analysis

Hantavirus: vaccine effectiveness following Andes virus exposure

Evidence of the protective efficacy of vaccines for hantavirus in people or animals exposed to Andes virus.

• From: UK Health Security Agency
• Published: 16 June 2026

Documents

Hantavirus vaccine effectiveness following Andes virus exposure: a systematic evidence summary

Ref: GOV-21184

PDF, 878 KB, 64 pages

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This systematic evidence summary (search up to 19 May 2026) identified and summarised evidence of the protective efficacy of vaccines for hantavirus in people or animals exposed to Andes virus.

Ten studies were included in this systematic evidence summary.

Published 16 June 2026